Prof. Martin Reck is Head of The Department of Thoracic Oncology, and Head of the Clinical Trial Department; Lung Clinic Grosshansdorf, Grosshansdorf, Germany.
Serving as principal investigator for numerous clinical trials in lung cancer, Prof. Reck’s specialisms include targeted therapeutics and personalised medicine for NSCLC. He enjoys authorship on over 150 peer-reviewed publications in NSCLC on a plurality of areas encompassing: driver-targeted therapies, combination systemic and targeted solutions, management of metastases, treatment sequencing, and novel therapeutics.
Prof. Reck is also principal investigator for the German Centre for Lung Research, and holds memberships with organisations including: ASCO, ESMO, IASLC, the German Working Group for Lung Cancer, and the German Cancer Society. Prof. Reck also works closely with international congresses, and has spoken at meetings such as ASCO and ESMO 2021.
EM-103443 - Date of preparation: June 2022